[Historical development of drug testing in Swiss equestrian sports]. / Geschichtliche Entwicklung und Analyse der Medikationskontrollen im Schweizer Pferdesport.

INTRODUCTION: The goal of this study was to describe the development of equine drug testing in horses in Switzerland. This was achieved through evaluation of a film made by the Institute of Forensic Medicine at the University of Basel entitled 'Doping von Rennpferden' [Doping of Race Horses], toxicological detection, 1962', the analysis of doping test results of the Swiss Equestrian Federation and by interviewing individuals of various professions who were involved in equine drug testing at the time. The study compares early and modern methods of drug testing and highlights the changes in the attitude of equestrian athletes, horse owners and the general public toward doping in equestrian sports. The high sensitivity of modern analytical methods allows the detection of drugs at levels considerably below therapeutic concentrations. This has resulted in a shift from zero tolerance for Controlled Medication Substances to the establishment of sub-therapeutic threshold concentrations. The lists of performance-enhancing drugs used in doping are updated continually. It became clear from this work that in the early 1960s, Switzerland played a leadership role in anti-doping in equestrian sports, and that the efforts to keep the sport free of performance-enhancing drugs remain exemplary.

INTRODUCTION: Le but du présent travail était d'étudier les débuts des contrôles de médication dans le sport équestre suisse. Il comprend l'analyse du film "Dopage de chevaux de course, mise en évidence toxicologique", un film de 1962 de l'Institut médico-légal de Bâle, une enquête auprès de témoins de l'époque provenant de divers milieux et l'exploitation des résultats des analyses de dopage de la Fédération Suisse des Sports Equestres (FSSE). Ces recherchent montrent comment les contrôles antidopage étaient effectués à l'époque en comparaison à aujourd'hui et comment le positionnement des cavaliers, des propriétaires et de la population en général sur cette question s'est modifiée au cours des années. Vu la très haute sensibilité des méthodes d'analyse utilisées actuellement, de nombreuses substances peuvent être aujourd'hui détectées dans des concentrations sans effet pharmacologique. Cela a conduit pour les médicaments contrôlés (Controlled Medication Substances) a une tendance à l'abandon de la "tolérance zéro" et à l'utilisation de valeurs-limites sans effet thérapeutique. Les listes des substances dopantes sont continuellement mises à jour. Les résultats de cette étude montrent que la Suisse, au début des années soixante, a joué un rôle de précurseur dans le contrôle de médication dans les sports équestres et que ses efforts pour le maintien d'un sport équestre propre restent exemplaires aujourd'hui.

[Do we need a quality control for horse shoes and farriery]. / Wird eine Qualitätssicherung beim Hufbeschlag nötig?

In the past few years marked changes in the field of farriery have been noted. In addition to the classical farrier, many new occupations concerned with hoof care have emerged, such as hoof trimmer, hoof technician, hoof orthopedist and hoof naturopath. Furthermore, a tremendous number of hoof protection systems have been developed, with an ever-increasing application to horses. However, regulations regarding alternative shoeing methods are insufficient and it is not clear, who governs the quality of the work of the individuals involved. Thus, a neutral authority composed of farriers and veterinarians should be formed to develop guidelines for the education of individuals involved with hoof care and for the distribution of various farriery products.

Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype: lesson from transgenic and knockout mice.

The binding of bradykinin (BK) to its B2 receptor results in a wide spectrum of biological effects including vasodilation, smooth muscle contraction and relaxation, pain, and inflammation. In order to gain a better insight into the physiological function of this potent vasoactive peptide, murine models have been created by the use of gene insertion or deletion. The results of studies using these strategies are revisited in the present article. In transgenic mice harboring the human BK B2 receptor cDNA (cHBKR), expression of the transgene was identified in the aorta, brain, heart, lung, liver, kidney, uterus and prostate gland by RT-PCR Southern blot analysis. These mice displayed an exaggerated hypotensive response to intra-aortic injection of BK, whereas the blood pressure of knockout mice, homozygous for targeted disruption of the endogenous gene, was insensitive to BK. Two transgenic mouse lines expressing the human BK B2 receptor showed a significant reduction of systolic tail-cuff blood pressure (84 +/- 1 mm Hg, n = 28; 80 +/- 1 mm Hg, n = 24; P < 0.001) compared with the control littermates (97 +/- 1 mm Hg, n = 52). Systolic blood pressure was elevated in BK B2 receptor knockout mice (124 +/- 1 mm Hg, n = 38). In heterozygous mice, systolic blood pressure was similar to that of controls until 5 month-old, then it raised to the elevated levels of knockout mice at 7 months of age. Together these data indicate that kinins acting through the B2 receptor play a role in the development of the blood pressure phenotype.

Reprocessing of reusable medical devices.

Advances in medical science and, in particular, minimally invasive surgical and diagnostic procedures have stimulated the development of new and improved medical devices. This has been made possible because of developments in engineering and material sciences. The design of devices for reusability is particularly important in an effort to provide cost effective healthcare. Concerns and issues include the ability to safely and effectively reprocess the devices, infection prevention and control, safety of the patient and healthcare worker, environmental concerns, and effective use of resources. From an infection prevention point of view, present requirements are based upon the intended use of the devices. Critical devices require sterilization. Semi-critical devices require, as a minimum, high level disinfection. Sterilization is, however, preferred whenever possible. Before sterilization or disinfection, devices should be cleaned adequately. Device designs should be readily amenable to cleaning and sterilization. In the past, design requirements focused primarily on the clinical user and device functionality, with reuse considerations left to the user. In the current market, the customer is redefined and, for reusable medical devices, includes all those associated with the device through the reprocessing procedure. In addition, regulations require that manufacturers give detailed instructions for reprocessing medical devices. The device users have the obligation to follow reprocessing instructions. Many choices exist today in device designs, including disposable or reusable devices. The user needs to balance cost versus convenience and reprocessing requirements for reusables. Current trends are to reuse more devices, including many of which were meant to be disposable. Cost effective designs can best be achieved when the user and manufacturer work together on the design.(ABSTRACT TRUNCATED AT 250 WORDS)

Synovial sarcoma of the soft palate: report of a case.

A case of primary synovial sarcoma of the soft palate is reported in a 19 year old man who was in good health and free of recurrence one year after operation. Radiation therapy was selected and a dose of 7600 rads was given. The presence of hyaluronic acid was investigated using the critical electrolyte concentration method. The tumor was considered histogenetically to be derived from undifferentiated mesenchymal tissue.